Table 1.
Clinical and demographic characteristics of the sample (pilot phase).
Sample | Data |
---|---|
Subjects | 5 |
Age, mean (SD) | 39 (11.31) |
Gender, n (%) | |
Male | 1 (20) |
Female | 4 (80) |
Pharmacotherapy | |
Antidepressant drug, n (%) | 1 (20) |
Mood stabilizer, n (%) | 3 (60) |
Antipsychotic, n (%) | 3 (60) |